BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:39:00 PM | Browse: 566 | Download: 417
Publication Name World Journal of Gastroenterology
Manuscript ID 5459
Country/Territory China
Received
2013-09-10 08:22
Peer-Review Started
2013-09-11 16:23
To Make the First Decision
2013-10-22 16:49
Return for Revision
2013-10-22 19:03
Revised
2013-10-28 12:49
Second Decision
2013-11-18 21:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-19 12:24
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-12-06 06:23
Typeset the Manuscript
2013-12-11 16:59
Publish the Manuscript Online
2014-01-20 16:41
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence
Manuscript Source Invited Manuscript
All Author List Zhong-Ming Tan and Bei-Cheng Sun
Funding Agency and Grant Number
Corresponding author Bei-Cheng Sun, MD, PhD, Liver Transplantation Center of the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. sunbc@njmu.edu.cn
Keywords Hepatocelluar carcinoma; Antiviral therapy; Carcinogenesis; Recurrence; Nucleos(t)ide analogues; Interferon; Retrospective study; Clinical trial
Core Tip Chronic hepatitis B virus (HBV) infection is the key driving force of hepatocellular carcinoma (HCC). In this review, we discussed the mechanism of HBV induction of HCC and described the current trends in anti-HBV therapy. The associations of anti-HBV therapy with prevention of HCC incidence and recurrence after curative operations were also summarized. Moreover, based on our center's experiences, a standardized antiviral strategy was suggested which greatly benefited those patients who underwent hepatectomy and liver transplantation with regard to better clinical results.
Publish Date 2014-01-20 16:41
Citation Tan ZM, Sun BC. Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence. World J Gastroenterol 2013; 19(47): 8895-8901
Url http://www.wjgnet.com/1007-9327/full/v19/i47/8895.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i47.8895
Full Article (PDF) WJG-19-8895.pdf
Manuscript File 5459-Review.doc
Answering Reviewers 5459-Answering Reviewers.pdf
Copyright License Agreement 5459-Copyright Assignment.pdf
Peer-review Report 5459-Peer Review(s).pdf
Scientific Editor Work List 5459-Scientific editor work list.doc